Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Peschanski

Showing results (101-110 of 116) with videos related to

Pageof 12
Sort By:
Nature Neuroscience|May 23, 2001
Shc signaling in differentiating neural progenitor cellsL Conti, S Sipione, L Magrassi, et al.
Gene Therapy|January 1, 1996
Targeting widespread sites of damage in dystrophic muscle: engrafted macrophages as potential shuttlesE P Parrish, C Cifuentes-Diaz, Z L Li, et al.
Experimental Neurology|May 30, 1998
MRI-stereotactical approach for neural grafting in basal ganglia disordersS Palfi, J P Nguyen, P Brugieres, et al.
Journal of Stem Cells & Regenerative Medicine|April 3, 2014
Direct myocardial implantation of human embryonic stem cells in a dog model of Duchenne cardiomyopathy reveals poor cell survival in dystrophic tissueW Habeler, B Ghaleh, I Barthelemy, et al.
Nature|March 27, 1997
Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's diseaseD F Emerich, S R Winn, P M Hantraye, et al.
Neurology|April 26, 2001
Retest effects and cognitive decline in longitudinal follow-up of patients with early HDA C Bachoud-Lévi, P Maison, P Bartolomeo, et al.
Stereotactic and Functional Neurosurgery|January 1, 1997
Intracerebral transplantation of fetal ventral mesencephalon for patients with advanced Parkinson's disease. Methodology and 6-month to 1-year follow-up in 3 patientsM Levivier, S Dethy, F Rodesch, et al.
Human Gene Therapy|June 2, 2000
Restoration of cognitive and motor functions by ciliary neurotrophic factor in a primate model of Huntington's diseaseV Mittoux, J M Joseph, F Conde, et al.
Human Gene Therapy|August 24, 2000
Neuroprotective gene therapy for Huntington's disease using a polymer encapsulated BHK cell line engineered to secrete human CNTFA C Bachoud-Lévi, N Déglon, J P Nguyen, et al.
Brain : a Journal of Neurology|February 1, 1996
Long-term outcome of unilaterally transplanted parkinsonian patients. I. Clinical approachG L Defer, C Geny, F Ricolfi, et al.
Pageof 12

Showing results (101-110 of 116) with videos related to

Sort By:
Pageof 12
Nature Neuroscience|May 23, 2001
Shc signaling in differentiating neural progenitor cellsL Conti, S Sipione, L Magrassi, et al.
Gene Therapy|January 1, 1996
Targeting widespread sites of damage in dystrophic muscle: engrafted macrophages as potential shuttlesE P Parrish, C Cifuentes-Diaz, Z L Li, et al.
Experimental Neurology|May 30, 1998
MRI-stereotactical approach for neural grafting in basal ganglia disordersS Palfi, J P Nguyen, P Brugieres, et al.
Journal of Stem Cells & Regenerative Medicine|April 3, 2014
Direct myocardial implantation of human embryonic stem cells in a dog model of Duchenne cardiomyopathy reveals poor cell survival in dystrophic tissueW Habeler, B Ghaleh, I Barthelemy, et al.
Nature|March 27, 1997
Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's diseaseD F Emerich, S R Winn, P M Hantraye, et al.
Neurology|April 26, 2001
Retest effects and cognitive decline in longitudinal follow-up of patients with early HDA C Bachoud-Lévi, P Maison, P Bartolomeo, et al.
Stereotactic and Functional Neurosurgery|January 1, 1997
Intracerebral transplantation of fetal ventral mesencephalon for patients with advanced Parkinson's disease. Methodology and 6-month to 1-year follow-up in 3 patientsM Levivier, S Dethy, F Rodesch, et al.
Human Gene Therapy|June 2, 2000
Restoration of cognitive and motor functions by ciliary neurotrophic factor in a primate model of Huntington's diseaseV Mittoux, J M Joseph, F Conde, et al.
Human Gene Therapy|August 24, 2000
Neuroprotective gene therapy for Huntington's disease using a polymer encapsulated BHK cell line engineered to secrete human CNTFA C Bachoud-Lévi, N Déglon, J P Nguyen, et al.
Brain : a Journal of Neurology|February 1, 1996
Long-term outcome of unilaterally transplanted parkinsonian patients. I. Clinical approachG L Defer, C Geny, F Ricolfi, et al.
Pageof 12